Conversion of a Viral Glycan Shield into a Binding Anchor via Causal-Driven Antibody Optimization
Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling.
Coevolving Mutations in Chronic SARS-CoV-2 Infections
Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach
DextraDemixer enables accurate identification of antigen-specific T cells from pMHC multimer experiments
Quantitative modeling of SARS-CoV-2 replication reveals phase-specific bottlenecks and antiviral targets
Expanded protocadherin-1 usage reveals a broader hantavirus entry landscape
Adjuvant selection for optimally balanced humoral and cellular immunity induced by SARS-CoV-2 Spike virosome vaccines
Scalable Production of a De Novo SARS-CoV-2 Antiviral miniprotein in Escherichia coli
DNA-barcode labelled MHCII multimers for detection of antigen-specific CD4 T cells across large libraries of epitopes
Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound
Multi-Scale Machine Learning for Antibody-Antigen Binding Affinity Prediction Using Deep Mutational Scanning and Structural Features
Forecasting virus evolution by integrating genotype–phenotype–epidemiology
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis
Forecasting virus evolution by integrating genotype–phenotype–epidemiology
Forecasting virus evolution by integrating genotype–phenotype–epidemiology
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis
Reporters Talk Through FDA Sunscreen Move and Closure of Rural Dialysis Clinics
Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
Efforts To End School Vaccine Mandates Hit a Wall in Florida
Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
Workers with long COVID more likely to leave jobs, lose productivity
Welcome! Everything is fine…except there is still no ACIP quorum: The State of US Vaccine Policy
Study suggests 2025-26 COVID vaccine cuts emergency, urgent care visits by half
Updated COVID vaccines cut risk of hospital care, heart complications, new data reveal